LCHF DIET

2. 1
(Fat & reproductive health)
" ".
.
.
.
. ..
.
.
.ஐ. .
.
.
, , , ,
,

3. 2
. .
,
.
,
.
. ,
,
..
.
" 1920
"
120
.
??
, ,
" " .

4. 3
1. வெஜைனா எனும் ைனனப்பாஜை(birth canal)
2. யூட஭ஸ் எனும் ர்ப்ப ஜப
3. ஓெரிகள் எனும் சிஜனப்ஜப
.
, ,
.
" "
- .
(an ovulation) . (anovulatory cycles)
.

5. 4
-
.
PCOD .
.
, .
, , ,
.
.
. .
" " (acanthosis nigricans) .
.
PCOD
. ,
.
" " .
.
, . hyper androgenism
.

6. 5
,
,
.
.
,
, PCOS . ,
.
.
.
!!!
PCOD , obesity , insulin
resistance
????
.
(
)
..
(http://dli.serc.iisc.ernet.in/…/Ke…/English/1736/655_W_O.pdf)

7. 6
..
..
!!
??
..
.
.
, .
,
, , ஐ , ,
.
.
, .
PCOD
" "
.
, .
,
, .
(https://www.ncbi.nlm.nih.gov/m/pubmed/25132280/)

8. 7
(https://www.ncbi.nlm.nih.gov/m/pubmed/17329264/)
,
,
.
!!!
" "
???
.
.
" (gut flora )” .
, .
, .
,
.
.
.

9. 8
" "
.
.
.
( pH <4.5)
.
, vaginal commensal bacteria .
Bacterial vaginosis, candida .
(white discharge ) .
,
.
(Pelvic inflammatory disease,
Salphingitis)
எப்படி நல்ல பபக்டீரி஬ாக்கஜை ெைர்த்துக்வகாள்ெது??
,
,
.
,
Candida albicans .
,

10. 9
.
,
.
, ,
( probiotics)
.
, , -ஈ ,
.
.
" "(reproductive period)
.
12-14 (menarche)
.
45 50 (menopause) .
1. ஈ

11. 10
2.
.
,
,
.
.
,
.
,
.
, .
..
??
/ / 365
.
45 - 50
30
.
"ஈ " .
ஈ 45
, .

12. 11
ஈ
.. ..
..
, ஈ
.
ஈ
(endometrium) .
??
. .
.
, -
..
,
.
.
.
.
, .
(Anovulation)
,
.
, ஈ
.

13. 12
, ,
(adipose tissue)
ஈ .
, ஈ
. endometrial hyperplasia. .
endometrial hyperplasia
.
(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964851/)
40
(International Agency for Research on Cancer (2014). World Cancer Report 2014. World Health
Organization. Chapter 5.12)
1980 . -
("Endometrial Cancer". Williams Gynecology (2nd ed.). McGraw-Hill. p. 817)
BMI 5 Kg/m2
62% .
,
,
.
,
,
.
.

14. 13
(low carb
high fat diet ) .
83 missed
.
..
.
.
300 முட்ஜடகஜைக்
.
.
.
" " .
??
,
(scrotum)
.
.
(
)

15. 14
..
.
,
.
??
.
.
.
.
,
.
.
ெிந்ைணு-முட்ஜட -> கருொக உருவெடுக்கும்
.
.
??
??
85 missed

16. 15
" - ??"
!!!
.
.
, , .
, ,
.
.
( mutations) , .
.
.
.
.
.
.
.

17. 16
.
.
// , 2
. 1 // .
.
1 -
.
2 - .
( insulin resistance)
. ( beta cell failure)
. ?
1
. ,
, .
HbA1C ( )
.
1 .
“
. ”
.
fatty liver , hepatitis B
. .
,
.

18. 17
.
medical renal disease .
diabetic nephropathy .
diabetic nephropathy -
.
.
.
,
.
. End stage renal diseaseஐ
.
protocol
.
.
fatty liver
.
fatty liver . .
Hepatitis B carrier
.
Hepatitis B .
“ ”
.
.
, .
, .
.
.

19. 18
.
(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215472/)
, (hyperinsulinemia)
.
.
.
(https://www.ncbi.nlm.nih.gov/m/pubmed/22215126/)
// . 65 .
30 / 5 //
. 60-70 , 25 , 5
.
.
( 1 1.5
)
1.
2.
3.
4.
5.
.
.
, , ,
.

20. 19
animal protein .
, , .
plant proteins .
animal proteins
. bio availability . Plant proteins
. , ,
.
86 missed
87 missed
" "
?
??
.
.
(alkaline)
.
,
.
,
.

21. 20
,
.
ஐ
.
benign prostatic hyperplasia .
BPH.
.
.
(ultra sound examination)
.
prostate specific antigen (serum PSA ) . PSA
.
(Fowke JH, Motley SS, Cookson MS, Concepcion R, Chang SS, Wills ML, Smith-Jr JA "The
association between body size, prostate volume and prostate-specific antigen)
,
.
.
(https://www.ncbi.nlm.nih.gov/m/pubmed/20553919/)
.
(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757152/)
,
.

22. 21
(http://www.jscimedcentral.com/…/translationalmedicine-2-103…)
, ,
,
(https://www.sciencedaily.com/releas…/2016/…/160405182105.htm)
??
-
-
-
-
-
- 30
-
.
- ???
.
1. (rheumatoid arthritis)
2. systemic lupus erythematosus (SLE)

23. 22
3.
4. (vitiligo)
5. ( psoriasis)
6. (leucoderma)
.
???
. . 1900
. . 2000 ???
.
.
hereditary risk factor .
.
...
..
..
..
" " .
.

24. 23
-
??
.
.
.
ஐ
.
???
,
???
..
..

25. 24
??
.
??
.
.
.
.
.
"pace setter" .
..
1. ந஫து வ஫டபாலிசத்ஜை உந்துெது
2. உணவுகஜை ைீ஭ணம் வசய்ெது
3. ைீ஭ண஫ான உணவுகஜை உடஜல கி஭கித்துக்வகாள்ை வசய்ெது
4. இை஬த்ஜை சீ஭ாக துடிக்கச் வசய்ெது

26. 25
5. வபண்கைில் ஫ாைெிடாஜ஬ சீ஭ாக நிகழச்வசய்ெது
6. உடல் எஜடஜ஬ ப஭ா஫ரிப்பது
7. க்ளூபகாஸ் ஫ற்றும் வகாழுப்பு வ஫டபாலிசத்ஜை சீ஭ாக இ஬ங்கச்வசய்ெது
-
(hypothyroidism )
(hyperthyroidism)
Graves' disease
. .
.
.
.
.
.

27. 26
.
.
.
.
(thyrotropin releasing hormone )
.
,
(thyroid stimulating hormone)
TSH ,
.
, TSH
.
TSH
.
negative Feed back mechanism .
TSH
. " " (hypothyroidism)
.
TSH
. " " (hyperthyroidism)
.
.

28. 27
TSH receptor antibodies
Anti Thyroid peroxidase antibodies (TPO ANTIBODIES)
.
???
,
.
.
"ஐ (itis) "
.
(thyroiditis)
vasculitis
.
(gluten)
. (antigen) .
(gliadin)
.
,
.
molecular mimicry .
,
,
.

29. 28
.
,
gut bacteria .
(stress ) ,
gut bacteria .
,
-
-
- ,
- ஐ .
- , ,
.
- , , ,
, ,
.
- ,
.
.
,
.

30. 29
.
???
(environmental changes)
( hereditary ) .
.
26
10,000 , 100
???
??
.
,
.
.
.
Arthritis .
??
" " (transfat)
??
??
. .
,
" "(hydrogenation)
" " .

31. 30
.
"leaky gut syndrome" .
.
, ,
.
,
. , .
, , .
,
.
.
,
"free radicals" .
free radicals .
,
.
, ,
, , ,
.
,
.
, .
Erythrocyte sedementation rate
.

32. 31
C-reactive proteins
.
,
disease modifying anti rheumatoid drugs
(DMARDs) .
.
1. ,
2. .
3. .
4. , , ஈ ,
5. , , , ,
6. , , ,
.
7. , ,
.
8. .
.

33. 32
(PSORIASIS)
.
.
.
.
" "
.
2
,
.

34. 33
(infection)
(psychological stress)
.
1. (plague psoriasis vulgaris ) 90%
2. Guttate psoriasis
3. Inverse psoriasis ( )
4. Pustular -
5. Erythrodermic psoriasis ( )
, ,
.
??
(epidermis)
.
28
30
3 5
.
.
?
(emollients )
(vitamin-D)

35. 34
(UV-B therapy )
PUVA therapy
.
??
.
..
??
.
.
??
1. .
, .
.
2.
.
Gut health
.
, , leaky gut
.

36. 35
ஐ
/ /
3.
4. , ,
5. .
, , .
6. 20 .
.
.
7. 3 (
) . 3
.
8.
.
.
9. .
.
.
10.
.
.
.

37. 36
.
TYPE I DIABETES
.
30- 40 .
.
,
.
.
.
,
,
(HYPERGLYCEMIA)

38. 37
.
,
.
.
-
.
-
.
.
.
,
???
.
.
??
.
.
?
/ /

39. 38
??
.
.
.
.
???
, ,
.
.

40. 39
.
.